機器人(300024.SZ):在機器人與智能裝備業務領域聚焦主要方向為工業機器人等核心產品領域
格隆匯4月27日丨有投資者在投資者互動平台向機器人(300024.SZ)提問,“貴公司曾隆重推出過智能機器人鬆鬆,目前的研發進展和市場推廣怎麼樣?”
機器人回覆稱,公司目前在機器人與智能裝備業務領域聚焦的主要方向為工業機器人、移動機器人、特種機器人3大核心產品領域,以及焊接自動化、裝配自動化、物流自動化3大應用技術,並基於對上述相關產品及技術的積累在下游行業,如汽車(包括新能源汽車)、半導體、鋰電、電子、光伏、航天航空及醫療等行業進行市場拓展和客户端的產品導入。目前已有的應用於其他領域內的智能機器人產品視市場需求情況開展相關業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.